HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus [Phase 2]
Phase 2 clinical trial evaluating the pharmacokinetics, pharmacodynamics, and safety of maraviroc (UK-427,857) in patients with HIV infectio…
-
CLINICAL_TRIALS trial_result · 2010-11-09Clinical Trial Update: Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection
This clinical trial update discusses discontinuation of antiretroviral therapy in patients with asymptomatic HIV infection, outlining observ…
-
CLINICAL_TRIALS trial_result · 2010-11-05Clinical Trial Update: A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects. [Phase 1]
Phase 1 study in healthy subjects evaluating interactions between simvastatin, atorvastatin, rosuvastatin, and GSK2248761; the trial has com…
-
FDA approval · 2010-11-04FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Zidovudine by Aurobindo Pharma Limited for an existing Zidovudine product.
-
FDA approval · 2010-11-04FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Zidovudine by Aurobindo Pharma Limited, granting continued approval for this generic HIV drug.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-11-04Clinical Trial Update: Investigation of V520 in a HIV Vaccine Dose Refinement Study (V520-027)(TERMINATED) [Phase 2]
This Phase 2 study evaluating HIV vaccine V520-027 was terminated; Merck posted results in 2010.
-
CLINICAL_TRIALS trial_result · 2010-11-03Clinical Trial Update: Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs [Phase 1]
This Phase 1 drug interaction study completed evaluating how darunavir/ritonavir and lopinavir/ritonavir affect the pharmacokinetics of GSK2…
-
CLINICAL_TRIALS trial_result · 2010-11-01Clinical Trial Update: PK of Tenofovir, Emtricitabine and Efavirenz in Healthy Volunteers [Phase 1]
Phase 1 pharmacokinetic study of the combination of tenofovir disoproxil fumarate, emtricitabine, and efavirenz in healthy volunteers; the s…
-
CLINICAL_TRIALS trial_result · 2010-11-01Clinical Trial Update: NNRTI/PI Toxicity Switch to Darunavir Study [Phase 4]
A Phase 4 HIV trial evaluating switching from an NNRTI/PI regimen to darunavir due to toxicity was terminated.
-
CLINICAL_TRIALS trial_result · 2010-10-28Clinical Trial Update: Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients [Phase 4]
This Phase 4 clinical trial update reports on adherence, efficacy, and tolerability of a once-daily nevirapine-based regimen in HIV-1 infect…
-
CLINICAL_TRIALS trial_result · 2010-10-28Clinical Trial Update: Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia [Phase 4]
A Phase 4 trial evaluating switching from efavirenz to nevirapine in people with HIV and dyslipidemia, focusing on LDL cholesterol changes.
-
CLINICAL_TRIALS trial_result · 2010-10-26Clinical Trial Update: TMC278-TiDP15-C150: Trial to Examine Safety, Tolerability and Plasma Pharmacokinetics of Multiple Doses of TMC278LA. [Phase 1]
A Phase 1 trial evaluating safety, tolerability, and plasma pharmacokinetics of multiple doses of the long-acting rilpivirine formulation TM…
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects [Phase 2, Phase 3]
A Phase 2/3 trial comparing maraviroc added to optimized background therapy versus optimized background therapy alone in antiretroviral-expe…
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients [Phase 4]
This record summarizes the completion of a Phase 4 clinical trial evaluating pegylated interferon therapy for acute hepatitis C infection in…
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men. [Phase 3]
Phase 3 GRACE trial update evaluating the effectiveness, safety and tolerability of darunavir/ritonavir in HIV-positive women and men, with …
-
CLINICAL_TRIALS trial_result · 2010-10-15Clinical Trial Update: A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744 [Phase 1]
Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of GSK1265744 (cabotegravir) in healthy volunteers and HIV patients;…
-
CLINICAL_TRIALS trial_result · 2010-10-15Clinical Trial Update: KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects [Phase 4]
Phase 4 trial comparing KIVEXA (abacavir/lamivudine) vs TRUVADA (emtricitabine/tenofovir) both with efavirenz in ART-naive HIV patients. Res…
-
CLINICAL_TRIALS trial_result · 2010-10-13Clinical Trial Update: Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects [Phase 3]
Phase 3 trial comparing once-daily Tenofovir disoproxil fumarate/emtricitabine/efavirenz versus zidovudine/lamivudine with efavirenz in anti…
-
CLINICAL_TRIALS trial_result · 2010-10-06Clinical Trial Update: A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring [Phase 1]
Phase 1 safety study evaluating the delivery of dapivirine from a matrix vaginal ring for HIV prevention has completed.
-
CLINICAL_TRIALS trial_result · 2010-10-05Clinical Trial Update: SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function
A completed clinical trial evaluating switching nucleoside analogue antiretroviral therapy to address lipoatrophy and mitochondrial function…
-
CLINICAL_TRIALS trial_result · 2010-10-04Clinical Trial Update: A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy [Phase 3]
Phase 3 trial update on a fixed-dose tablet containing two FDA-approved HIV drugs for treatment-naive patients; the study status is complete…
-
FDA approval · 2010-10-01FDA Approved: COMBIVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Combivir (lamivudine and zidovudine) from ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2010-09-30Clinical Trial Update: A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study) [Phase 3]
Phase 3 trial comparing the safety of once-daily single-tablet abacavir/lamivudine versus twice-daily separate tablets in HIV infection. The…
-
CLINICAL_TRIALS trial_result · 2010-09-22Clinical Trial Update: A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN) [Phase 3]
Phase 3 study comparing once-daily darunavir/ritonavir 800 mg/100 mg to twice-daily 600 mg/100 mg in early treatment-experienced HIV-1 infec…
-
CLINICAL_TRIALS trial_result · 2010-09-17Clinical Trial Update: Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses [Phase 2]
A Phase 2 trial evaluating the efficacy of a triple-drug regimen (darunavir/ritonavir, etravirine, and raltegravir) in HIV patients with res…